KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Work In Process (2018 - 2025)

Globus Medical's Work In Process history spans 8 years, with the latest figure at $63.7 million for Q3 2025.

  • For Q3 2025, Work In Process rose 46.12% year-over-year to $63.7 million; the TTM value through Sep 2025 reached $63.7 million, up 46.12%, while the annual FY2024 figure was $45.8 million, 22.65% up from the prior year.
  • Work In Process reached $63.7 million in Q3 2025 per GMED's latest filing, up from $60.4 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $63.7 million in Q3 2025 to a low of $16.8 million in Q2 2021.
  • Average Work In Process over 5 years is $31.3 million, with a median of $23.6 million recorded in 2023.
  • Peak YoY movement for Work In Process: dropped 18.8% in 2021, then soared 101.93% in 2023.
  • A 5-year view of Work In Process shows it stood at $17.4 million in 2021, then increased by 7.46% to $18.7 million in 2022, then surged by 99.59% to $37.3 million in 2023, then grew by 22.65% to $45.8 million in 2024, then surged by 39.11% to $63.7 million in 2025.
  • Per Business Quant, the three most recent readings for GMED's Work In Process are $63.7 million (Q3 2025), $60.4 million (Q2 2025), and $48.0 million (Q1 2025).